Contribution: Industrial Research Assistance Program – Contributions to Firms
Spa Dent Inc.
$200,000.00
Enzymatic Oral Analgesics
FY 2024-25 · 2024-05-12
Summary
Analgesic gels containing Benzocaine, a local anesthetic, among other potential APIs will be developed to include proteolytic enzymes and saliva producing/retention ingredients to help reduce oral inflammation for a more natural approach to healing. This benzocaine and enzymatic system, along with the proposed addition of hyaluronic acid, will aid patients post dental surgery in recovery without requiring opioid prescriptions, such as codeine. This will decrease the overreliance on opioids for post-oral surgery recovery, potentially reducing the rate of opioid addiction.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Waterloo|Waterloo, Ontario, Canada
Recipient Type
For-profit organization
Business Number
812687424
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
As published
Agreement End Date
2025-03-31
Agreement Number
1020996
Agreement Start Date
2024-05-12
Agreement Title
Enzymatic Oral Analgesics
Agreement Title (French)
Analgésiques oraux enzymatiques
Agreement Type
Contribution
Agreement Value
$200,000.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Analgesic gels containing Benzocaine, a local anesthetic, among other potential APIs will be developed to include proteolytic enzymes and saliva producing/retention ingredients to help reduce oral inflammation for a more natural approach to healing. This benzocaine and enzymatic system, along with the proposed addition of hyaluronic acid, will aid patients post dental surgery in recovery without requiring opioid prescriptions, such as codeine. This will decrease the overreliance on opioids for post-oral surgery recovery, potentially reducing the rate of opioid addiction.
Description (French)
Des gels analgésiques contenant de la benzocaïne, un anesthésique local, parmi d’autres API potentiels, seront développés pour inclure des enzymes protéolytiques et des ingrédients produisant/rétention de salive pour aider à réduire l’inflammation buccale pour une approche plus naturelle de la guérison. Cette benzocaïne et ce système enzymatique, ainsi que l’ajout proposé d’acide hyaluronique, aideront les patients ayant subi une chirurgie dentaire à se rétablir sans avoir besoin de prescriptions d’opioïdes, tels que la codéine. Cela diminuera la dépendance excessive aux opioïdes pour le rétablissement post-chirurgie buccale, réduisant potentiellement le taux de dépendance aux opioïdes.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Waterloo
Federal Riding (French)
Waterloo
Federal Riding Number
35112
NAICS Code
44612
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
812687424
Recipient City
Waterloo|Waterloo
Recipient Country
CA
Recipient Legal Name
Spa Dent Inc.
Recipient Postal Code
N2K 3T6
Recipient Province or Territory
ON
Recipient Type
F
Reference Number
172-2024-2025-Q2-1020996
